Holen Sie sich die Stockscreener-App
150.38
5.42%
7.73
Handel nachbörslich:
149.91
-0.47
-0.31%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$142.65
Offen:
$145.6
24-Stunden-Volumen:
23.00M
Relative Volume:
2.00
Marktkapitalisierung:
$188.88B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
33.14
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+1.98%
1M Leistung:
-0.86%
6M Leistung:
+85.52%
1J Leistung:
+107.02%
1-Tages-Spanne:
$144.43
$152.56
1-Wochen-Bereich:
$135.50
$154.37
52-Wochen-Spanne:
$56.32
$167.15
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
150.38 | 179.17B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
987.82 | 375.17B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
230.91 | 178.45B | 28.37B | 7.00B | 5.70B | 8.6769 |
|
KLAC
Kla Corp
|
1,136.73 | 144.15B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
165.97 | 24.89B | 2.83B | 469.17M | 568.90M | 2.8828 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research (NASDAQ:LRCX) Trading Up 5.4% After Analyst Upgrade - MarketBeat
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
This Is What Whales Are Betting On Lam ResearchLam Research (NASDAQ:LRCX) - Benzinga
Prudential Financial Inc. Has $133.38 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Atalanta Sosnoff Capital LLC Invests $65.45 Million in Lam Research Corporation $LRCX - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Grows Position in Lam Research Corporation $LRCX - MarketBeat
What Are Wall Street Analysts’ Target Price for Lam Research Corporation Stock? - MSN
Coldstream Capital Management Inc. Has $16.05 Million Position in Lam Research Corporation $LRCX - MarketBeat
Stevens Capital Management LP Purchases New Stake in Lam Research Corporation $LRCX - MarketBeat
Richard W. Paul & Associates LLC Buys 1,779 Shares of Lam Research Corporation $LRCX - MarketBeat
Rhumbline Advisers Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Evelyn Partners Investment Management Services Ltd Buys 37,668 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stake Increased by Franklin Resources Inc. - MarketBeat
Handelsbanken Fonder AB Cuts Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Position Reduced by Personal CFO Solutions LLC - MarketBeat
Lam Research opens $65 million office building in Oregon By Investing.com - Investing.com Nigeria
/C O R R E C T I O N -- Lam Research Corporation/ - Yahoo Finance
Lam Research (NASDAQ:LRCX) Trading 2.2% HigherShould You Buy? - MarketBeat
Lam Research Opens 120,000 SQFT Office Facility in Tualatin in to Accelerate Semiconductor Industry Leadership in AI Era - The Registry Pacific Northwest Real Estate
Lam Research opens $65M office in Oregon in response to expanding semiconductor demand - MSN
Lam Research unveils new Oregon facility as chipmaker rebounds from downturn - The Business Journals
Lam Research opens $65 million office building in Tualatin, Oregon - StreetInsider
Lam Research opens $65M building in Tualatin, with more growth in the works - The Business Journals
Lam Research Corporation $LRCX Holdings Raised by Swiss National Bank - MarketBeat
JPMorgan Chase & Co. Purchases 5,102,589 Shares of Lam Research Corporation $LRCX - MarketBeat
DNB Asset Management AS Buys 566,754 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Trading Down 6.2%Here's What Happened - MarketBeat
Applied Materials: Up 40% in 2025 With Room to Run Long-Term - Investing.com
GDS Wealth Management Buys 32,930 Shares of Lam Research Corporation $LRCX - MarketBeat
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial - Yahoo Finance
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Top Stock Reports for Walmart, Intuitive Surgical & Lam Research - Yahoo Finance
Lam Research Corporation stock volume spike explainedWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com
Frank Rimerman Advisors LLC Sells 18,181 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. Opens with a 5.12% Gain Amid Market Decline - Markets Mojo
ARS Investment Partners LLC Acquires 4,504 Shares of Lam Research Corporation $LRCX - MarketBeat
Avantax Advisory Services Inc. Raises Stock Position in Lam Research Corporation $LRCX - MarketBeat
NAA LARGE CAP VALUE FUND's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corporation Announces Participation at Upcoming Conference - Finviz
Lam Research (NASDAQ:LRCX) Shares Down 2.9% After Insider Selling - MarketBeat
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research (NASDAQ: LRCX) to join UBS Global Technology and AI Conference on Dec. 2 - Stock Titan
Vanguard Group Inc. Has $12.71 Billion Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Purus Wealth Management LLC Acquires Shares of 2,740 Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Nomura Asset Management Co. Ltd. - MarketBeat
Rockefeller Capital Management L.P. Has $27.34 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Black Creek Investment Management Inc. Increases Stock Position in Lam Research Corporation $LRCX - MarketBeat
One Giant Leap for AI Physics: NVIDIA Apollo Unveiled as Open Model Family for Scientific Simulation - NVIDIA Blog
Lam Research (NASDAQ:LRCX) CFO Sells $6,036,048.00 in Stock - MarketBeat
LAM Research CFO Sells Over $6 Million in Company Stock - TradingView
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.08%
2.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):